CRT 2017 : FDA VALVE - CRT Valve & Structural - FDA - PFO Closure: Current State and Future Directions

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
No longer available for purchase

Overview

FDA VALVE - CRT Valve & Structural - FDA - PFO Closure: Current State and Future Directions

Featuring

  • Andrew Farb
  • Richard Benson
  • Jon Resar
  • Dan Gutfinger
  • Kenneth Stein
  • David Holmes Jr
  • Rachel Neubrander
  • Megan Coylewright

Add this Moment to your Passport

Learn from this moment and keep it forever.
No longer available for purchase

Moment Components

FDA Considerations for the Labeling and Future Trials - Andrew Farb
Who Should I Refer for PFO Closure and What Studies I Would Like to See - The Neurologist Perspective - Richard Benson
Now Approved, How Do We Utilize It - Cardiology Perspective - Jon Resar
PFO Closure - Industry Perspective - Dan Gutfinger
Lessons From WATCHMAN Launch: FDA, CMS, and the Launch of a New Therapy - Kenneth Stein, MD
LAA Occlusion Post-Approval Studies: Opportunities for use of Registries - David Holmes Jr.
Looking Forward: New Clinical Trial Design – The FDA Perspective - Rachel Neubrander
Patient Selection for LAA Closure: The Role of Shared Decision Making - Megan Coylewright

Target Audience

Learning Objectives

Related Moments

ISCP 2017 - Treatment of Heart Failure in 2017 - Joint Session ISCP and Cardio Vascular Clinical Trialist forum (I)
Course
CRT 2015 Technology & Innovation - Renal Denervation: Review of the Data and Lessons from the Studies
Conference
A session on Renal Denervation and a Review of the Data and Lessons from the Studies from CRT 2015
CRT 2017 : MASTERS TRANSRADIAL INTERVENTION - Optimize PCI Outcomes: The Necessity of Vessel Preparation for Complex Calcified Disease
Roundtable
Loading Simple Education